Smith & Nephew (LON:SN) Given New GBX 1,700 Price Target at Royal Bank Of Canada

Key Points

• Royal Bank of Canada increased Smith & Nephew's price target from GBX 1,400 to GBX 1,700, indicating a potential upside of 26.25% from the current stock price.
• Analysts from Deutsche Bank and Berenberg Bank have also raised their price targets on the stock, with both giving it a "hold" rating, showing varied yet positive sentiment towards Smith & Nephew.
• Insider trading activity has been notable, with company insiders purchasing a total of 4,811 shares valued at approximately £12,947,701 in the last ninety days.

Smith & Nephew (LON:SN - Get Free Report) had its target price boosted by investment analysts at Royal Bank Of Canada from GBX 1,400 to GBX 1,700 in a research report issued on Monday,Digital Look reports. The firm currently has an "outperform" rating on the stock. Royal Bank Of Canada's target price points to a potential upside of 26.25% from the stock's current price.

Several other analysts have also commented on SN. Deutsche Bank Aktiengesellschaft boosted their price target on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research note on Wednesday, August 6th. Berenberg Bank boosted their price objective on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a research note on Thursday, August 7th. Finally, JPMorgan Chase & Co. boosted their price objective on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an "overweight" rating in a research note on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of GBX 1,459.50.

Smith & Nephew Price Performance

Shares of SN stock opened at GBX 1,346.50 on Monday. The company has a market capitalization of £14.76 billion, a PE ratio of 48.48, a P/E/G ratio of 0.46 and a beta of 0.62. The business has a 50 day moving average price of GBX 1,363.60 and a two-hundred day moving average price of GBX 1,181.68. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Insiders Place Their Bets

In related news, insider Katarzyna Mazur Hofsaess acquired 541 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was acquired at an average price of GBX 1,385 per share, for a total transaction of £7,492.85. Also, insider Jeremy (Jez) Maiden purchased 353 shares of the stock in a transaction on Friday, August 22nd. The stock was acquired at an average price of GBX 1,378 per share, with a total value of £4,864.34. Insiders have purchased a total of 4,811 shares of company stock valued at $12,947,701 in the last ninety days. 0.19% of the stock is currently owned by insiders.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.